PDCD1 and cancer: Together with our results, these studies provide evidence that several chemotherapeutic drugs have the capacity to induce PD-L1 expression, which may itself mediate the chemotherapy resistance on the one hand [46], but also provide the rationale for combined cancer treatment of chemotherapeutic drugs and anti-PD-1/PD-L1 mAbs on the other hand.